Cesar A. Bravo, M.D.
NPI 1245216530ActiveIndividual· Internal Medicine, Nephrology· Houston, TX
Internal Medicine, Nephrology (M.D.) in Houston, Texas, licensed in TX, with an NPI issued in December 2005. Their prescriptions cost Medicare Part D more than their services did: $495,169 for 2,530 claims, against $49,228 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 12 companies reporting payments in 2025, $653.75 in all, mostly food and beverage.
Overview
| NPI | 1245216530 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Dec 19, 2005 |
| Last updated in NPPES | Sep 1, 2026 |
| Certified by provider | Sep 1, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Nephrology Primary | 207RN0300X | E9550 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Nephrology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 94 |
|---|---|
| Services billed | 359 across 7 procedure codes |
| Paid by Medicare | $49,228 |
Part D prescriptions in 2024
| Prescriptions (claims) | 2,530 · 6,214 30-day fills |
|---|---|
| Patients | 345 |
| Total drug cost | $495,169 |
| Generic share | 82% of claims |
Education and affiliations
| Graduation year | 1967 |
|---|---|
| Medicare specialty | Nephrology |
| Secondary specialties | Internal Medicine |
Other facilities
- Spring Branch DialysisDialysis facility · Houston, TX
Industry payments (Open Payments)
- 2025$653.75 · 29 payments from 12 companies
- 2024$806.71 · 39 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $206.36 | 8 |
| Bayer Healthcare Pharmaceuticals Inc. | $120.04 | 6 |
| Ardelyx, Inc. | $50.84 | 2 |
| Travere Therapeutics, Inc. | $44.71 | 2 |
| Novartis Pharmaceuticals Corporation | $41.94 | 2 |
What the 2025 payments were for
- Food and Beverage$633.53 · 28 payments
- Education$20.22 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Nephrology providers in Houston
- 1003471533
- 1659560613
- 1073172698
- 1659768729
- 1710051396
- 1679774715
- 1295078590
- 1841438280
- 1013155340
- 1902150683
- 1659340529
- 1457384885